We observed a numerically longer PFS and OS for patients with a decreased level of eccDNA compared to those with an increased level of eccDNA, but they did not reach statistical significance.
← all excerpts
Plasma extrachromosomal circular DNA as a biomarker in EGFR-targeted therapy of non-small cell lung cancer.
1
—
—